International Development Grant
Shaping Local Markets for Diarrhea Treatment
Project Number: CA-3-A035457001
Status: Closed
Country/Region:
Maximum Contribution: $14,098,097.00
Start Date: March 11, 2014
End Date: July 31, 2017
Duration: 3.4 years
Project Description
This project aims to reduce the number of children under the age of five who are dying from diarrhea in five Nigerian states. This project works closely with communities the Government of Nigeria and the private sector to build a sustainable local market for oral rehydration salts and zinc - the recommended treatment for diarrhea. Combined these two simple highly effective and affordable treatments can reduce the likelihood of diarrhea deaths in young children by up to 93%. The project works to encourage investment by Nigerian pharmaceutical importers and manufacturers to ensure a better supply of these low-cost treatments in Nigeria and better distribution of the treatments in clinics and private shops in hard-to-reach areas. This innovative private-sector oriented project also seeks to educate caregivers and health workers in the use of oral rehydration salts and zinc to effectively and safely treat diarrhea in children. The project aims to increase the use of these life-saving treatments - from less than 1% currently to over 50% by 2017 - to reach an estimated 4.2 million children.
Expected Results
The expected intermediate outcomes for this project include: increased demand for oral rehydration salts and zinc among caregivers and health providers in five focal states; increased supply by manufacturers and importers of affordable high-quality oral rehydration salts and zinc in five focal states; expanded distribution of oral rehydration salts and zinc to clinics and private shops in rural and hard-to-reach areas.
Progress & Results Achieved
Results achieved as of the end of the project (March 2017) include: (1) an increase in the percentage of children under the age of five who received oral rehydration solution and zinc (ORS/zinc) to treat diarrhea from a baseline of 6% to 37% which saved the lives of an estimated 12 359 children from 2014 to 2017 in the five targeted states of Nigeria: Bauchi Katsina Kaduna Niger and Cross River; (2) an improved supply chain of ORS/zinc led to a reduction in the market price of ORS/zinc treatments by 68%; and (3) more than 35 000 public and private sector providers were trained on the benefits of ORS/zinc to treat children with diarrhea in all five focal states.
Key Information
Executing Agency:
Clinton Health Access Initiative
Reporting Organization:
Global Affairs Canada
Program:
WGM Africa
Last Modified:
September 19, 2025
Development Classifications
DAC Sector:
Aid Type: Project-type interventions
Collaboration: Bilateral
Finance Type: Aid grant excluding debt reorganisation
Selection Mechanism:
Pre-APP